<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Both nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS) inhibitors and free radical scavengers have been shown to protect brain tissue in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury </plain></SENT>
<SENT sid="1" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> act via distinct mechanisms and react together to form the highly deleterious <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore the authors examined the effects and the interaction between the NOS inhibitor, NG <z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (<z:chebi fb="17" ids="48010">LNA</z:chebi>) and the <z:chebi fb="11" ids="22586">antioxidant</z:chebi>/<z:chebi fb="1" ids="18421">superoxide</z:chebi> scavenger, di-<z:chebi fb="0" ids="30355">tert-butyl</z:chebi>-<z:chebi fb="0" ids="50778">hydroxybenzoic acid</z:chebi> (DtBHB) in the rat submitted to 2 hours of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Posttreatment was initiated 4 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was measured at 48 hours </plain></SENT>
<SENT sid="4" pm="."><plain>The dose-related effect of <z:chebi fb="17" ids="48010">LNA</z:chebi> resulted in a bell-shaped curve: 15, 56, 65, and 33% reduction of total <z:mpath ids='MPATH_124'>infarct</z:mpath> for 0.03, 0.1, 0.3, and 1 mg/kg (intravenously [IV]) respectively and 11% increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume for 3 mg/kg (IV) </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas DtBHB (20 mg/kg; intraperitoneally [IP]) was ineffective, the dose of 60 mg/kg produced 65% protection in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="6" pm="."><plain>The combination of a subthreshold dose of <z:chebi fb="17" ids="48010">LNA</z:chebi> (0.03 mg/kg; IV) and DtBHB (20 mg/kg; IP) resulted in significant reduction (49%) in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="7" pm="."><plain>These results show that <z:chebi fb="17" ids="48010">LNA</z:chebi> and DtBHB act synergistically to provide a consistent neuroprotection against ischemic injury when administered 4 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and free radicals are involved and interact in synergy in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury </plain></SENT>
</text></document>